Companies › BLCO
Bausch Lomb Corp (BLCO)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001860742 · EDGAR filings · Updated 2026-06-16
Bausch Lomb Corp (BLCO) has reported institutional ownership of 0.2%, with 1 institutional managers holding positions valued at $8.53M per the latest 13F reporting period. SEC filings include an active bankruptcy or receivership filing (8-K Item 1.03), non-reliance notice on previously issued financial statements (8-K Item 4.02), triggering event that accelerates or increases a direct financial obligation (8-K Item 2.04).
Latest updates
- 2026-06-16 — Insider transaction reported (Form 4)
- 2026-06-01 — SD filed
- 2026-05-28 — Insider transaction reported (Form 4)
- 2026-05-28 — Insider transaction reported (Form 4)
- 2026-05-28 — Insider transaction reported (Form 4)
- 2026-05-28 — Insider transaction reported (Form 4)
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, Bausch Lomb Corp has 1 institutional holders and institutional ownership of 0.2%.
Insider activity
Insiders reported 80 transactions (11 buys, 0 sells) across 18 reporting insiders, with a net reported value of $1.49M.
Data flags from SEC filings
Related companies
Curis Inc (CRIS) · TVARDI THERAPEUTICS INC COM (TVRD) · RENOVORX INC (RNXT) · SS INNOVATIONS INTERNATIONAL COM NEW (SSII) · VISTAGEN THERAPEUTICS INC (VTGN) · TherapeuticsMD Inc (TXMD)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-16.